China Pharma Holdings, Inc.
CPHI· NYSE
Filed Aug 14, 2012 · 10-Q · 45 days after period end · 0001010549-12-000896
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $14.60M | $19.60M | $16.63M |
| Net Income | $1.76M | $5.07M | $6.08M |
| EPS Diluted | $0.04 | $0.12 | $0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end